Cubist Systematic Strategies’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-137
Closed -$347 4447
2023
Q4
$347 Buy
+137
New +$319 ﹤0.01% 3490
2023
Q3
Sell
-6,109
Closed -$14.1K 4145
2023
Q2
$14.1K Sell
6,109
-35,580
-85% -$100K ﹤0.01% 3219
2023
Q1
$106K Sell
41,689
-23,869
-36% -$68.4K ﹤0.01% 3430
2022
Q4
$165K Sell
65,558
-33,868
-34% -$94.5K ﹤0.01% 3669
2022
Q3
$288K Sell
99,426
-100,861
-50% -$425K ﹤0.01% 3542
2022
Q2
$905K Sell
200,287
-140,825
-41% -$838K 0.01% 2563
2022
Q1
$2.74M Buy
341,112
+123,139
+56% +$1.09M 0.02% 1225
2021
Q4
$2.54M Buy
+217,973
New +$2.61M 0.02% 1167

Cubist Systematic Strategies's SLGC Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 137 shares — an estimated $347 sold.

Cubist Systematic Strategies first reported a position in SLGC in Q4 2021 and held it in 8 quarters. The position peaked at $2.74M in Q1 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Cubist Systematic Strategies reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 137 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $347.
  • Cubist Systematic Strategies first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2021 and held it in 8 quarters.
  • Cubist Systematic Strategies's SomaLogic, Inc. Class A Common Stock position peaked at $2.74M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.